A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
Cornell researchers “humanized” mice with microbiota from three global populations and found that microbial differences alone can impact immune responses.
Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.
The 2020 nationwide lockdown India imposed in response to the COVID-19 pandemic caused disruptions that negatively impacted women’s nutrition, according to a new study from the Tata-Cornell Institute for Agriculture and Nutrition.
Researchers at Weill Cornell Medicine have identified neurons that drive animal brains to initiate actions without prompting from food or prey – a big step toward solving a big unanswered questions in neuroscience.
A new study describes how an interdisciplinary team of Cornell researchers used a state-of-the-art microscopy technique to reveal protein structures and key steps of a CRISPR-Cas system that holds promise for developing an improved gene editing tool.
The specialized endothelial cells that line the blood vessels in the lung may hold the key to treating the common and often-fatal lung disease emphysema, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
The genetic changes that underlie an especially lethal type of prostate cancer, called neuroendocrine prostate cancer, have been revealed in a new study at Weill Cornell Medicine. Learning more about what causes this type of cancer could lead to new approaches for treating it.
Black patients who have chronic liver failure, also known as end-stage liver disease, are less likely to be placed on a waiting list for a life-saving liver transplant than other racial and ethnic groups, according to a study.
